Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc.

Bullboard Posts

Comment by kevinNashon Jul 06, 2018 6:31pm

190 Views

Post# 28280083

RE:RE:RE:wall at .54 and .55

On the wkly chart, the 5 week MA has triggered a much bigger uptrend. 5 week MA is 60 cents right now. Weekly Middle BB is 90 cents. Upper BB is 1.54. Both the weekly STO & RSI are well into oversold territory and historically the weekly STO has made full swings putting the share price well above this level potentially filling that gap down from 1.10s

Annayya wrote: Nice close at 55 cents. With the deal expected very soon, we should see more volume next week moving the SP into the 60s and higher as shorts begin covering significantly as we approach August.

With 5 big pharma competing for the deal (or buyout), finalizing a deal could be quicker. The fact that 2 new companies are interested in the deal shows that we have a very good product.

biotech1973 wrote:
GONEEEE.. This is going to move now.. I can smell that..